ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $162,056 | -3.0% | 45,267 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $167,035 | +11.5% | 45,267 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $149,834 | -27.6% | 45,267 | -15.1% | 0.01% | -33.3% |
| Q4 2022 | $206,858 | +59.1% | 53,314 | 0.0% | 0.01% | +28.6% |
| Q3 2022 | $130,000 | +22.6% | 53,314 | 0.0% | 0.01% | +40.0% |
| Q2 2022 | $106,000 | +8.2% | 53,314 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $98,000 | +28.9% | 53,314 | -1.6% | 0.01% | +66.7% |
| Q4 2021 | $76,000 | +24.6% | 54,186 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $61,000 | -29.9% | 54,186 | 0.0% | 0.00% | -25.0% |
| Q2 2021 | $87,000 | -3.3% | 54,186 | +6.1% | 0.00% | 0.0% |
| Q1 2021 | $90,000 | +30.4% | 51,070 | +44.6% | 0.00% | 0.0% |
| Q4 2020 | $69,000 | -13.8% | 35,309 | +5.4% | 0.00% | -20.0% |
| Q3 2020 | $80,000 | – | 33,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Biomark Capital Management Co. LLC | 1,433,304 | $6,464,000 | 99.88% |
| Broadfin Capital, LLC | 3,249,829 | $14,657,000 | 2.31% |
| Stonepine Capital Management, LLC | 831,731 | $3,751,000 | 2.28% |
| Aisling Capital LLC | 3,608,171 | $16,273,000 | 2.14% |
| Consonance Capital Management LP | 4,249,234 | $19,164,000 | 1.24% |
| MORGENS WATERFALL VINTIADIS & CO INC | 375,000 | $1,691,000 | 1.20% |
| Perceptive Advisors | 6,521,102 | $29,410,000 | 0.77% |
| PURA VIDA INVESTMENTS, LLC | 325,000 | $1,466,000 | 0.59% |
| 683 Capital Management, LLC | 885,000 | $3,991,000 | 0.27% |
| ARDSLEY ADVISORY PARTNERS LP | 80,000 | $361,000 | 0.05% |